16/04/2014 - 18:55
LONDON – A single daily pill containing two novel antiviral agents produced sustained virologic response rates of more than 90% in as little as 8-12 weeks in three multicenter, open-label phase III...
Field of Interest: Gastroentero...
Categories:
News Feed: Internal Medicine News - Gastroenterology